H. L. Seewann
- Hematology top 5%
- Genetics top 10%
- Oncology
- Molecular Biology
- Rheumatology
- Co-authors
- Klaus LechnerM Hinterberger-FischerP HöckerW HinterbergerH. HuberAlois LangHeinz LudwigAlfred Beham
- Topics
- Chronic Lymphocytic Leukemia Research (8 papers)Chronic Myeloid Leukemia Treatments (8 papers)Acute Myeloid Leukemia Research (7 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
H. L. Seewann
25 papers receiving 311 citations
Peers
Comparison fields: 5 of 45
- Hematology 208
- Genetics 109
- Oncology 102
- Molecular Biology 85
- Rheumatology 66
Countries citing papers authored by H. L. Seewann
This map shows the geographic impact of H. L. Seewann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. L. Seewann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. L. Seewann more than expected).
Fields of papers citing papers by H. L. Seewann
This network shows the impact of papers produced by H. L. Seewann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. L. Seewann. The network helps show where H. L. Seewann may publish in the future.
Co-authorship network of co-authors of H. L. Seewann
This figure shows the co-authorship network connecting the top 25 collaborators of H. L. Seewann. A scholar is included among the top collaborators of H. L. Seewann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. L. Seewann. H. L. Seewann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 25 | |
| 6 | 20 | |
| 7 | 9 | |
| 8 | 11 | |
| 9 | 69 | |
| 10 | 3 | |
| 11 | 9 | |
| 12 | 4 | |
| 13 | 1 | |
| 14 | 20 | |
| 15 | 23 | |
| 16 | 11 | |
| 17 | 44 | |
| 18 | 19 | |
| 19 | 1 | |
| 20 | 8 |
About H. L. Seewann
H. L. Seewann is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 27 papers that have together received 325 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Hematology (208 citations), Genetics (109 citations) and Rheumatology (66 citations). H. L. Seewann has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Klaus Lechner, M Hinterberger-Fischer, P Höcker, W Hinterberger, H. Huber, Alois Lang, Heinz Ludwig, Alfred Beham, David Nachbaur and Peter Günczler. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.